33. Fallon J, Tighe R, Kradjian G, Guzman W, Bernhardt A, Neuteboom B, Lan Y, Sabzevari H, Schlom J, Greiner JW: The immunocytokine NHS-IL12 as a potential cancer therapeutic. Oncotarget 2014, 5(7):1869-1884. 34. Strauss J, Heery CR, Kim JW, Jochems C, Donahue RN, Montgomery AS, McMahon S, Lamping E, Marte JL, Madan RA et al : First -in-Human Phase I Trial of a Tumor- Targeted Cytokine (NHS -IL12) in Subjects with Metastatic Solid Tumors . Clin Cancer Res 2019, 25(1):99 -109.